PYC 8.33% 11.0¢ pyc therapeutics limited

Ann: Retina Target Engagement Confirmed in Large Eye, page-76

  1. 5,184 Posts.
    lightbulb Created with Sketch. 1681
    Out of the job description for our strategy and corporate chief officer, applications close this Sunday.

    Our ideal candidate will be responsible for directing and coordinating the company's long and short term strategies, research and development and marketing activities with an overall goal of maximising investment.
    Responsible for overseeing business strategies to support PYC’s current pre clinical drug development programs and additional pipeline programs in 2022 ultimately into commercialisation. Expand our market capitalisation by working with investors, other Biotechnology and Pharmaceutical companies to expand the market capitalisation of PYC


    It is pretty much spelled out what to expect for the company following the tox data update.
    Perth based development and reasearch base needs to match up management capacity to engage with future partners and developers, expanded pipeline workload and coordination.

    all IMO
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
11.0¢
Change
-0.010(8.33%)
Mkt cap ! $513.2M
Open High Low Value Volume
12.0¢ 12.5¢ 11.0¢ $383.6K 3.159M

Buyers (Bids)

No. Vol. Price($)
5 169997 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
11.5¢ 1549 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.